Principal Financial Group Inc Haemonetics Corp Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$72.45 - $91.58 $2.71 Million - $3.43 Million	-37,433 Reduced 19.43%	155,259 $12.5 Million
Q2 2024 Jul 29, 2024	SELL	$81.24 - $97.37 $1.54 Million - $1.85 Million	-18,985 Reduced 8.97%	192,692 $15.9 Million
Q1 2024 Apr 29, 2024	BUY	$71.24 - $85.35 $549,474 - $658,304	7,713 Added 3.78%	211,677 $18.1 Million
Q4 2023 Feb 07, 2024	BUY	$80.59 - $92.61 $371,036 - $426,376	4,604 Added 2.31%	203,964 $17.4 Million
Q3 2023 Nov 02, 2023	BUY	$82.56 - $93.49 $69,680 - $78,905	844 Added 0.43%	199,360 $17.9 Million
Q2 2023 Aug 07, 2023	SELL	$80.84 - $89.45 $721,739 - $798,609	-8,928 Reduced 4.3%	198,516 $16.9 Million
Q1 2023 May 09, 2023	SELL	$72.75 - $90.6 $99,012 - $123,306	-1,361 Reduced 0.65%	207,444 $17.2 Million
Q4 2022 Feb 09, 2023	SELL	$73.85 - $86.14 $337,199 - $393,315	-4,566 Reduced 2.14%	208,805 $16.4 Million
Q3 2022 Nov 09, 2022	SELL	$63.3 - $78.66 $1.49 Million - $1.85 Million	-23,527 Reduced 9.93%	213,371 $15.8 Million
Q2 2022 Aug 10, 2022	BUY	$49.27 - $66.08 $2.69 Million - $3.61 Million	54,583 Added 29.94%	236,898 $15.4 Million
Q1 2022 May 09, 2022	SELL	$43.77 - $63.22 $56,113 - $81,048	-1,282 Reduced 0.7%	182,315 $11.5 Million
Q4 2021 Feb 09, 2022	BUY	$49.55 - $74.59 $139,086 - $209,374	2,807 Added 1.55%	183,597 $9.74 Million
Q3 2021 Nov 09, 2021	BUY	$57.6 - $70.59 $18,374 - $22,518	319 Added 0.18%	180,790 $12.8 Million
Q2 2021 Aug 10, 2021	SELL	$51.81 - $118.56 $10.4 Million - $23.7 Million	-200,077 Reduced 52.58%	180,471 $12 Million
Q1 2021 May 10, 2021	BUY	$111.01 - $139.48 $25.2 Million - $31.7 Million	227,285 Added 148.3%	380,548 $42.2 Million
Q4 2020 Feb 08, 2021	SELL	$88.75 - $119.95 $46,238 - $62,493	-521 Reduced 0.34%	153,263 $18.2 Million
Q3 2020 Nov 06, 2020	SELL	$75.65 - $93.58 $377,720 - $467,244	-4,993 Reduced 3.14%	153,784 $13.4 Million
Q2 2020 Aug 05, 2020	BUY	$84.96 - $118.91 $78,757 - $110,229	927 Added 0.59%	158,777 $14.2 Million
Q1 2020 May 12, 2020	SELL	$74.34 - $121.82 $4.87 Million - $7.97 Million	-65,443 Reduced 29.31%	157,850 $15.7 Million
Q4 2019 Feb 05, 2020	SELL	$114.37 - $129.46 $178,874 - $202,475	-1,564 Reduced 0.7%	223,293 $25.7 Million
Q3 2019 Nov 13, 2019	SELL	$117.16 - $138.52 $521,010 - $615,998	-4,447 Reduced 1.94%	224,857 $28.4 Million
Q2 2019 Aug 12, 2019	SELL	$81.74 - $120.34 $625,964 - $921,563	-7,658 Reduced 3.23%	229,304 $27.6 Million
Q1 2019 May 10, 2019	SELL	$83.25 - $102.12 $80,669 - $98,954	-969 Reduced 0.41%	236,962 $20.7 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $2.03 Million - $2.61 Million	-22,347 Reduced 8.59%	237,931 $23.8 Million
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $370,995 - $472,527	4,124 Added 1.61%	260,278 $29.8 Million
Q2 2018 Aug 13, 2018	SELL	$71.53 - $95.75 $13.6 Million - $18.2 Million	-190,294 Reduced 42.62%	256,154 $0
Q1 2018 May 14, 2018	BUY	$60.72 - $74.41 $975,952 - $1.2 Million	16,073 Added 3.73%	446,448 $32.7 Million
Q4 2017 Feb 13, 2018	SELL	$44.96 - $58.99 $28,684 - $37,635	-638 Reduced 0.15%	430,375 $25 Million
Q3 2017 Nov 02, 2017	BUY	$40.38 - $44.87 $17.4 Million - $19.3 Million	431,013	431,013 $19.3 Million

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$450 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$390 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$335 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$317 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$304 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account